Hydrophilic molybdenum oxide nanomaterials with controlled morphology and strong plasmonic absorption for photothermal ablation of cancer cells.

The molybdenum oxide nanosheets have shown strong localized surface plasmon resonance (LSPR) absorption in the near-infrared (NIR) region. However, the long alky chains of ligands made them hydrophobic and less biocompatible. To meet the requirements of molybdenum based nanomaterials for use as a future photothermal therapy, a simple hydrothermal route has been developed for hydrophilic molybdenum oxide nanospheres and nanoribbons using a molybdenum precursor and poly(ethylene glycol) (PEG). First, molybdenum oxide nanomaterials prepared in the presence of PEG exhibit strong localized surface plasmon resonance (LSPR) absorption in near-infrared (NIR) region, compared with that of no PEG. Second, elevation of synthetic temperature leads to a gradual transformation of molybdenum oxide nanospheres into nanoribbons, entailing the evolution of an intense LSPR absorption in the NIR region. Third, as-prepared molybdenum oxide nanomaterials coated with PEG possess a hydrophilic property and thus can be directly used for biological applications without additional post treatments. Moreover, molybdenum oxide nanoribbons as a model of photothermal materials can efficiently convert the 980 nm wavelength laser energy into heat energy, and this localized hyperthermia produces the effective thermal ablation of cancer cells, meaning a potential photothermal material.